Na Zhang
- Biomaterials top 0.1%
- Nanoparticle-Based Drug Delivery 74
- Pharmaceutical Science top 0.2%
- Immunology top 1%
- Immunotherapy and Immune Responses 34
- Immune Cell Function and Interaction 21
- Immune cells in cancer 18
- Cancer Research top 1%
- Molecular Biology top 1%
- RNA Interference and Gene Delivery 60
- Advanced biosensing and bioanalysis techniques 35
-
- Nanoplatforms for cancer theranostics 58
-
- Nanocluster Synthesis and Applications 21
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Na Zhang
441 papers receiving 12.1k citations
Peers
Comparison fields: 5 of 178
- Biomaterials 3.0k
- Pharmaceutical Science 996
- Immunology 1.8k
- Cancer Research 1.1k
- Molecular Biology 4.9k
Countries citing papers authored by Na Zhang
This map shows the geographic impact of Na Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Na Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Na Zhang more than expected).
Fields of papers citing papers by Na Zhang
This network shows the impact of papers produced by Na Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Na Zhang. The network helps show where Na Zhang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Na Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 9 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 8 | |
| 5 | 2024 | 5 | |
| 6 | 2024 | 6 | |
| 7 | 2024 | 20 | |
| 8 | 2024 | 3 | |
| 9 | 2024 | 7 | |
| 10 | 2023 | 11 | |
| 11 | 2023 | 6 | |
| 12 | 2023 | 6 | |
| 13 | 2023 | 9 | |
| 14 | 2022 | 10 | |
| 15 | 2021 | 7 | |
| 16 | 2019 | 20 | |
| 17 | 2019 | 12 | |
| 18 | 2018 | 132 | |
| 19 | 2018 | 73 | |
| 20 | 2017 | 10 |
About Na Zhang
Na Zhang is a scholar working on Biomaterials, Immunology and Oncology, having authored 460 papers that have together received 12.2k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (74 papers), RNA Interference and Gene Delivery (60 papers), Nanoplatforms for cancer theranostics (58 papers), Advanced biosensing and bioanalysis techniques (35 papers), Immunotherapy and Immune Responses (34 papers), Immune Cell Function and Interaction (21 papers), Nanocluster Synthesis and Applications (21 papers) and Immune cells in cancer (18 papers). The work is most often cited by research in Biomaterials (3.0k citations), Pharmaceutical Science (996 citations) and Immunology (1.8k citations). Na Zhang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Yongjun Liu, Chunxi Liu, Weiwei Mu, Lixia Feng, Zhihong Liu, Tianqi Wang, Yongjun Liu, Donghua Liu, Zhijin Chen and Qihui Chu. Their work appears in journals such as Nature, Advanced Materials and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.